Top of this page
Skip navigation, go straight to the content

Engagement in public policy

UCB engages actively in the UK policy environment, having regular interaction with government and legislators in Westminster as well as in the devolved administrations.

We are active in efforts to improve the UK as an environment in which to conduct research and development, particularly with regard to regulation of the biopharmaceutical industry.

As a top five pharmaceutical R&D investor in the UK, we support moves to give patients better access to innovative medicines through quicker adoption and uptake of new medicines.

We work with the ABPI and the BIA, patient groups and other stakeholders on these issues in discussion with government and government agencies.